The comparison of trial data-based and registry data-based cost-effectiveness of infliximab treatment for rheumatoid arthritis in Sweden using a modeling approach. [electronic resource]
Producer: 20130517Description: 251-8 p. digitalISSN:- 1524-4733
- Antibodies, Monoclonal -- economics
- Antirheumatic Agents -- economics
- Arthritis, Rheumatoid -- drug therapy
- Cohort Studies
- Cost-Benefit Analysis -- methods
- Data Collection -- standards
- Female
- Humans
- Infliximab
- Male
- Methotrexate -- economics
- Middle Aged
- Models, Economic
- Quality-Adjusted Life Years
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Registries -- statistics & numerical data
- Sweden
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.